Acibadem Healthcare Group
YUSUF KARAKAŞ
Assoc. Prof. M.D.

YUSUF KARAKAŞ

Medical Units and Clinical Services
  • Oncology

Assoc. Prof. Yusuf Karakaş is a medical oncologist with a strong clinical and academic background. He earned his medical oncology specialization from Hacettepe University Faculty of Medicine in 2017. Since 2019, he has been practicing at Acıbadem Health Group, where he provides comprehensive cancer care and participates in multidisciplinary treatment planning. He is an active member of the Turkish Medical Oncology association, staying engaged with current developments in oncology and contributing to professional collaboration and education. M.D. Karakaş combines evidence-based practice with patient-centered care, focusing on improving outcomes and quality of life for his patients.

Education

  • 2017 Hacettepe University Faculty of Medicine Medical Oncology
  • 2013 Osmangazi University Faculty of Medicine Internal Medicine
  • 2007 Hacettepe University Faculty of Medicine (Eng)

Experience

  • 2019 Acibadem Health Group
  • 2017 – 2019 Hakkari State Hospital / The first and only doctor appointed to Hakkari in the history of the Republic to work here

Memberships

  • Turkish Medical Oncology

Publications

  • Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience
    The TurkishJournal of Gastroenterology, 31(2), 91-98., Doi: 10.5152/tjg.2020.18919 KARAKAS YUSUF,LAÇIN SAHIN,KURTULAN OLCAY,ESIN ECE,SUNAR VELI,SOKMENSUER CENK,,KILIÇKAP, SAADETTIN,YALÇIN SUAYIB.
  • Multimodality Treatment in Malignant Peripheral Nerve Sheath Tumors
    Journal of Oncological Science, 6(1), 23-28., Doi: 10.37047/jos.2019-73127, KARAKAS YUSUF,DIZDAR ÖMER,KÖSEMEHMETOGLU KEMAL,BOZBULUT UTKU BURAK,Demir Metin,GEDIKOGLU MUSTAFA GÖKHAN,SÖYLEMEZOGLU AYSE FIGEN,TÜRKER FATMA ALEV,Kars
  • Evaluation of Cancer Types and Prevalence in Hakkari Province
    (2019).Acibadem Universitesi Saglik Bilimleri Dergisi, 11(4), 724-728., Doi: 10.31067/0.2019.235, KARAKAS YUSUF
  • Recent advances in the management of pancreatic adenocarcinoma
    Expert Review of Anticancer Therapy, 18(1), 51-62., Doi:10.1080/14737140.2018.1403319, KARAKAS YUSUF,LAÇIN SAHIN,YALÇIN SUAYIB.
  • The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival
    Clinical. Breast Cancer, 18(4), 320-327., Doi: 10.1016/j.clbc.2017.11.002, KARAKAS YUSUF,DIZDAR ÖMER,AKSOY SERCAN,HAYRAN KADIR MUTLU, ALTUNDAĞ KADRİ.
  • Kaposi’s Sarcoma Epidemiology, Risk Factors, Staging and Treatment: AN OVERVIEW
    Acta Oncologica Turcica, 50(2), 148-159.Doi: 10.5505/aot.2017.59023. KARAKAS YUSUF,AKSOY SERCAN,GÜLLÜ IBRAHIM HALIL
  • Tumor Sidedness and Prognosis in Colorectal Cancer
    JAMA Oncology, 3(7), 1000, Doi: 10.1001/jamaoncol.2017.0034 KARAKAS YUSUF,DIZDAR ÖMER.
  • Analysis of the Adjuvant Hormone Therapy Randomized Tria
    Journal of Clinical Oncology, 34(17), 2070-2070., Doi:10.1200/JCO.2015.65.4277 KARAKAS YUSUF,Akin Serkan,DIZDAR ÖMER,AKSOY SERCAN.




×
Logo

29 hospitals and 15 medical centers in 5 countries.

About Us
Hospitals
Treatments
Doctors
Medical Technologies
Check Up Packages
Appointment
Blog
Health Library
Contact Us
Promotional
About Us

At ACIBADEM Healthcare Group, we are committed to healthcare excellence and providing world-class healthcare services to our patients. As a leader in international healthcare, we strive to deliver the highest quality of care and meet the needs of our diverse patient population.

Read More...
Appointment FormLive Support
Manage your privacy

We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional
Always active
Preferences
Statistics